Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Nihin Media Inc., in collaboration with Professor Ken Yamamoto of the Faculty…
M2X Inc. is pleased to announce that KM Biologics Co., Ltd. has…
Veeva Systems announced that Boehringer Ingelheim has launched its own drug discovery…
Ubie Inc. will begin offering the "Ubie Generative AI Service Special Package"…
LPIXEL Inc. has begun business collaboration with Software Service Co., Ltd. By…
Medapp Inc., which develops, develops and sells products to improve hospital management,…
Iole Co., Ltd. is pleased to announce that it has begun collaborating…
Josh Inc. is pleased to announce that it has raised funds in…
Sign in to your account